Signals
Platform Powered By EquityPandit

Cash Intraday
Signals

Option
Signals

Stock Future
Intraday Signals

Swing Trading
Signals

Investment
Opportunities

Stock
Signals

Join Now

Balaxi Pharmaceuticals Ltd

NSE :BALAXI   BSE :532597  Sector : Pharmaceuticals
Buy, Sell or Hold BALAXI? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

13 Nov
74.81
(-3.51%)
12 Nov
77.53
(-4.40%)
11 Nov
81.10
(-5.74%)
08 Nov
86.04
(-0.72%)
07 Nov
86.66
(-0.30%)
06 Nov
86.92
(-3.39%)
05 Nov
89.97
(1.87%)
04 Nov
88.32
(-2.93%)
01 Nov
90.99
(1.16%)
31 Oct
89.95
(-0.03%)
30 Oct
89.98
(0.17%)
29 Oct
89.83
(0.66%)
28 Oct
89.24
(1.46%)
25 Oct
87.96
(-1.40%)
24 Oct
89.21
(-1.41%)
23 Oct
90.49
(-1.47%)
22 Oct
91.84
(-3.48%)
21 Oct
95.15
(-0.28%)
18 Oct
95.42
(-1.35%)
17 Oct
96.73
(3.68%)
16 Oct
93.30
(-0.27%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bearish
Medium Term Investors

Very Bearish
Long Term Investors

Very Bearish

Moving Averages

5 DMA
Bearish

81.23

10 DMA
Bearish

85.23

20 DMA
Bearish

88.41

50 DMA
Bearish

98.59

100 DMA
Bearish

105.8

200 DMA
Bearish

110.01


Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Nov 13, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 81.09 79.54 75.89 - -
R2 79.54 78.04 75.53 79.34 -
R1 77.17 77.12 75.17 76.77 78.36
P 75.62 75.62 75.62 75.42 76.22
S1 73.25 74.12 74.45 72.85 74.44
S2 71.7 73.2 74.09 71.5 -
S3 69.33 71.7 73.73 - -

Key Metrics

EPS

0.53

P/E

141.15

P/B

3.24

Dividend Yield

0%

Market Cap

413 Cr.

Face Value

2

Book Value

23.06

ROE

-25.94%

EBITDA Growth

5.48 Cr.

Debt/Equity

0.09

Shareholding Pattern

  65.99% Total Promoter Holding
0% Mutual Fund Holdings
16.48% FIIs
17.5% Non Institution
0% Insurance Companies
0% Custodians
0.03% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Balaxi Pharmaceuticals Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 60.65 62.29 59.14 63.77 73.27
PROFIT 9.23 12.03 9.9 6.48 4.59
EPS 14.1 13.29 10.41 1.17 0.84

Balaxi Pharmaceuticals Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 17.7 13.73 16.07 19.87 22.45
PROFIT 1.18 0.49 -0.58 1.38 1.66
EPS 1.16 0.48 -0.55 0.25 0.3

Profit & Loss (Figures in Rs. Crores)


Balaxi Pharmaceuticals Ltd Profit & Loss


Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 14.49 46.22 233.56 284.36 339.07 241.92
PROFIT 1.97 6.1 38.14 47.66 45.96 -49.83
EPS 1.29 1.22 7.63 9.53 9.03 -0.44

Balaxi Pharmaceuticals Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 0.24 0.05 0 0 14.49 46.22 88.68 104.04 114.74 72.6
PROFIT 0.1 -0.08 -0.17 -0.77 1.97 6.5 15.13 14.67 16.22 3.69
EPS 0.34 0 0 0 1.29 1.3 3.03 2.93 3.19 0.67

Balance Sheet (Figures in Rs. Crores)

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
SOURCES OF FUNDS :
Share Capital 10.910.181010103.04
Reserves Total 186.69162.4103.1654.9817.750.48
Equity Share Warrants3.7710.30000
Total Shareholders Funds201.36182.88113.1664.9827.753.52
Secured Loans 00.070.130.1500
Unsecured Loans 19.413.233.513.5100
Total Debt19.413.33.643.6600
Other Liabilities0.0400000
Total Liabilities220.8196.18116.868.6427.753.52
APPLICATION OF FUNDS :
Gross Block 42.984329.232.740.190.01
Less: Accumulated Depreciation2.11.60.470.300
Net Block40.8841.428.762.440.190.01
Capital Work in Progress2.312.830.57000
Investments 0003.4200
Inventories 82.17105.0298.713.620.830
Sundry Debtors 55.7152.2827.5676.7629.715.47
Cash and Bank Balance62.2928.227.191.6740.13
Loans and Advances 10.017.997.551.720.310.17
Total Current Assets210.17193.5114193.7734.865.78
Current Liabilities 33.6537.3352.3825.025.812.12
Provisions 2.885.067.256.012.420.47
Total Current Liabilities & Provisions36.5342.3859.6331.038.232.59
Net Current Assets173.64151.1381.3762.7426.643.19
Deferred Tax Liability11.10.040.0100
Net Deferred Tax-1-1.1-0.04-0.0100
Other Assets4.981.926.140.050.920.32
Total Assets220.81196.19116.868.6527.753.52
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 10.910.181010103.043.043.043.043.04
Reserves Total 106.8871.6347.9133.2518.110.48-1.49-0.720.110.18
Equity Share Warrants3.7710.300000000
Total Shareholders Funds121.5592.1157.9143.2528.113.521.552.323.153.22
Secured Loans 0.150.490.930000000
Unsecured Loans 15.5511.9513.5100000.20
Total Debt15.712.441.933.5100000.20
Other Liabilities0.04000000000
Total Liabilities137.29104.5559.8446.7628.113.521.552.323.353.22
APPLICATION OF FUNDS :
Gross Block 7.618.412.450.780.190.010.0100.010.01
Less : Accumulated Depreciation 0.510.520.250.0900000.010.01
Net Block 7.17.892.20.690.190.010.01000
Capital Work in Progress2.312.830.570000000
Investments 19.8819.5419.6119.540.10003.293.42
Inventories 0.841.4900.020.8300000
Sundry Debtors 76.7678.2952.1148.1331.225.470000.01
Cash and Bank Balance44.0617.880.840.483.570.131.652.340.010.02
Loans and Advances 1.241.361.120.051.080.17000.230.23
Total Current Assets122.999.0254.0848.6736.75.781.652.340.240.26
Current Liabilities 14.619.5717.2816.727.382.120.130.050.030.16
Provisions 1.474.514.755.442.410.470.0100.180.3
Total Current Liabilities & Provisions16.0724.0822.0322.169.792.590.130.050.220.46
Net Current Assets106.8374.9432.0426.5126.93.191.512.290.02-0.2
Deferred Tax Assets000000000.040
Deferred Tax Liability11.10.040.01000000
Net Deferred Tax-1-1.1-0.04-0.0100000.040
Other Assets2.180.445.460.020.920.320.030.0300
Total Assets137.29104.5559.8446.7528.113.521.552.323.353.22

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...2.02
Depreciation2.1
Interest (Net)1.68
Others0.04
Total Adjustments (PBT and Ext...-1.14
Operating Profit before Workin...0.87
Trade and 0ther Receivables-6.49
Inventories22.86
Trade Payables-5.48
Loans and Advances-0.25
Total Adjustments (OP before W...10.68
Cash Generated from/(used in) ...11.55
Direct Taxes Paid-6.68
Total Adjustments(Cash Generat...-6.68
Cash Flow before Extraordinary...4.87
Net Cash from Operating Activi...4.87
Purchased of Fixed Assets-1.57
as [Capital WIP0.52
Net Cash used in Investing Act...-1.05
Proceeds from Issue of shares ...25.79
Proceed from 0ther Long Term B...6.04
Of Financial Liabilities-0.09
Interest Paid-1.53
Net Cash used in Financing Act...30.25
Net Profit before Tax and Extr...5.58
Depreciation0.51
Interest (Net)1.54
Others0.04
Total Adjustments (PBT and Ext...2.05
Operating Profit before Workin...7.63
Trade and 0ther Receivables-0.21
Inventories0.66
Trade Payables-4.82
Loans and Advances0.07
Total Adjustments (OP before W...-4.39
Cash Generated from/(used in) ...3.24
Direct Taxes Paid-5.08
Total Adjustments(Cash Generat...-5.08
Cash Flow before Extraordinary...-1.83
Net Cash from Operating Activi...-1.83
Purchased of Fixed Assets-0.03
Sale of Fixed Assets0.32
Capital WIP0.52
Purchase of Investments-0.35
Net Cash used in Investing Act...0.47
Proceeds from Issue of shares ...25.79
Proceed from 0ther Long Term B...3.21
Of Financial Liabilities-0.09
Interest Paid-1.39
Net Cash used in Financing Act...27.55

Company Details

Registered Office
Address41/298-D2 2nd Flr Saniya Plaza,
Mahakavi Bharatiyar Road
CityCochin
StateKerala
Pin Code682035
Tel. No.91-484-4032952/6596725
Fax. No.
Emailsecretarial@anandamrubberco.com
Internethttp://www.balaxipharma.in
Registrars
Address41/298-D2 2nd Flr Saniya Plaza
CityCochin
StateKerala
Pin Code682035
Tel. No.91-484-4032952/6596725
Fax. No.
Emailsecretarial@anandamrubberco.com
Internethttp://www.balaxipharma.in
Management
Name Designation
Ashish MaheshwariChairman / Executive Director / M D / Promoter
Minoshi MaheshwariNon Executive Director
Kunal M BhaktaIndependent Non Exe. Director
Gandhi GamjiIndependent Non Exe. Director
M. Srinivas RaoIndependent Non Exe. Director
Purnima Singh KambleIndependent Non Exe. Director